Vivek Subbiah/LinkedIn
May 21, 2025, 06:44
Vivek Subbiah: Clinical Trials are Essential for Medical Advancement
Vivek Subbiah, Chief of Early-Phase Drug Development at Sarah Cannon Research Institute, posted on LinkedIn:
“Clinical trials are essential for medical advancement.
Clinical trials continue to evolve every day, improving the care and outcomes of cancer patients. However, we must keep driving forward by educating patients and providers, raising awareness about the effectiveness of clinical trials, and striving to make them accessible to every patient in need of treatment.
There are many myths about clinical trials. Swipe through to learn more.”
More posts featuring Vivek Subbiah.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 3, 2025, 12:18
Jul 3, 2025, 11:56
Jul 3, 2025, 11:29
Jul 3, 2025, 10:55
Jul 3, 2025, 10:25
Jul 3, 2025, 10:24